Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression profile in multiple myeloma tumors from Vk*MYC mice

ABSTRACT: Myeloma tumors arose in Vk*MYC mice share gene expression profile with multiple myeloma tumors from human patients

ORGANISM(S): Mus musculus

PROVIDER: GSE111921 | GEO | 2020/02/20

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Evaluation of CNAs in multiple myeloma tumors from Vk*MYC mice

Project description:Myeloma tumors arose in Vk*MYC mice share copy number abnormalities with multiple myeloma tumors from human patients

2020-02-20 | GSE110954 | GEO

Multiple myeloma tumors from Vk*MYC mice

Project description:Multiple myeloma tumors from Vk*MYC mice

| PRJNA438547 | ENA

Gene expression profile in multiple myeloma tumors from Vk*MYC mice

Project description:Gene expression profile in multiple myeloma tumors from Vk*MYC mice

| PRJNA438546 | ENA

Evaluation of CNAs in multiple myeloma tumors from Vk*MYC mice

Project description:Evaluation of CNAs in multiple myeloma tumors from Vk*MYC mice

| PRJNA435404 | ENA

Multiple myeloma tumors from Vk*MYC mice

Project description:This SuperSeries is composed of the SubSeries listed below.

2020-02-20 | GSE111922 | GEO

RNA-Seq, WGS, WXS of mouse myeloma tumors derived from Vk*MYC transgenic mice

Project description:Comprehensive genomic analysis (WXS, WGS, RNAseq) identifies shared pathways of progression between human and mouse myeloma.

2024-04-04 | GSE255233 | GEO

Bacillus safensis VK strain:VK

Project description:Bacillus safensis VK strain:VK Genome sequencing and assembly

| PRJNA210810 | ENA

Spontaneous onset and transplant models of the Vk*MYC mouse show immunological sequelae comparable to human multiple myeloma.

Project description:BackgroundThe Vk*MYC transgenic and transplant mouse models of multiple myeloma (MM) are well established as a research tool for anti-myeloma drug discovery. However, little is known of the immune response in these models. Understanding the immunological relevance of these models is of increasing importance as immunotherapeutic drugs are developed against MM.MethodsWe set out to examine how cellular immunity is affected in Vk*MYC mouse models and compare that to the immunology of patients with newly diagnosed and relapsed/refractory MM.ResultsWe found that there were significant immunological responses in mice developing either spontaneous (transgenic) or transplanted MM as a consequence of the degree of tumor burden. Particularly striking were the profound B cell lymphopenia and the expansion of CD8(+) effector memory T cells within the lymphocyte population that progressively developed with advancing disease burden, mirroring changes seen in human MM. High disease burden was also associated with increased inflammatory cytokine production by T lymphocytes, which is more fitting with relapsed/refractory MM in humans.ConclusionsThese findings have important implications for the application of this mouse model in the development of MM immunotherapies. Trial registration LitVacc ANZCTR trial ID ACTRN12613000344796; RevLite ANZCTR trial ID NCT00482261.

| S-EPMC5011922 | biostudies-literature

Genome-wide profiling of tumor cells in multiple myeloma

Project description:In multiple myeloma (MM), endothelial progenitor cells (EPCs) regulate tumor angiogenesis and disease progression. They share a common bone marrow microenvironment with myeloma tumor cells. CD138+ tumor plasma cells from 12 newly diagnosed patients with advanced MM were examined for genomic instability by RNA microarrays to assess changes in gene expression.

2011-04-02 | GSE28327 | GEO

Multiple myeloma

Project description:Multiple myeloma

| PRJNA515992 | ENA